Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 118350
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118350
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.118350
Table 3 Survival outcomes stratified by tumor grades and types
| Histologic diagnosis | n | Median survival (in months) | 95%CI |
| Low-grade tumors | 64 | 26 | 20.2-31.8 |
| Pilocytic astrocytoma | 32 | 30 | 24.7-35.2 |
| Oligodendroglioma | 32 | 18 | 11.6-24.3 |
| High-grade tumors | 64 | 3 | 2.0-3.9 |
| Glioblastoma multiforme | 16 | 2 | 0.8-3.1 |
| Anaplastic astrocytoma | 16 | 4 | 2.4-5.5 |
| Anaplastic oligodendroglioma | 30 | 2 | 0.5-3.4 |
| Gliosarcoma | 2 | 2 | 0.8-3.1 |
- Citation: Nasir S, Ali A, Ullah I, Wazir S, Javaid I, Jalal SZ, Khan I, Mubarak M. Clinicopathological and prognostic relevance of nestin in low- and high-grade gliomas: An immunohistochemical study. World J Clin Oncol 2026; 17(5): 118350
- URL: https://www.wjgnet.com/2218-4333/full/v17/i5/118350.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i5.118350